Finance

Lists
Why is 000766 down 2,01%?
Dive Deeper
000766:SHE
Tonghua Golden-Horse Pharmcl Indu Co Ltd
CN¥14,15
-2,01%
(-0,29) 1D
16 Okt., 14:42:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000766...
Open
CN¥14,64
High
CN¥14,73
Low
CN¥14,11
Mkt. cap
13,91 mjd
Avg. vol.
10,75 m
Volume
9,95 m
P/E ratio
555,99
52-wk high
CN¥30,20
52-wk low
CN¥14,11
EPS
CN¥0,03
Shares outstanding
966,49 m
No. of employees
1 k
Open
CN¥14,64
High
CN¥14,73
Low
CN¥14,11
Mkt. cap
13,91 mjd
Avg. vol.
10,75 m
Volume
9,95 m
P/E ratio
555,99
52-wk high
CN¥30,20
52-wk low
CN¥14,11
EPS
CN¥0,03
Shares outstanding
966,49 m
No. of employees
1 k
News stories
From web sources and news partners
About Tonghua Golden-Horse Pharmcl Indu Co Ltd
CEO-
Employees1,48 k
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitethjm.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
242,27 m
277,71 m
300,10 m
257,06 m
Cost of goods sold
71,09 m
80,32 m
75,48 m
66,19 m
Cost of revenue
71,09 m
80,32 m
75,48 m
66,19 m
Research and development expenses
9,37 m
11,86 m
15,10 m
12,46 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131,64 m
158,19 m
176,52 m
150,20 m
Operating expense
137,83 m
177,83 m
194,24 m
170,32 m
Total operating expenses
208,92 m
258,14 m
269,72 m
236,52 m
Operating income
33,35 m
19,56 m
30,38 m
20,54 m
Other non operating income
246,07 k
-3,93 m
-67,59 k
877,62 k
EBT including unusual items
10,38 m
8,13 m
9,99 m
1,49 m
EBT excluding unusual items
14,03 m
-505,23 k
9,88 m
654,22 k
Income tax expense
2,24 m
-1,09 m
869,78 k
3,60 m
Effective tax rate
21,59%
-13,39%
8,71%
241,57%
Other operating expenses
-4,06 m
10,87 m
2,61 m
4,00 m
Net income
8,16 m
9,32 m
9,13 m
-2,02 m
Net profit margin
3,37%
3,36%
3,04%
-0,79%
Earnings per share
-
-
-
-
Interest and investment income
961,06 k
4,78 m
358,62 k
1,07 m
Interest expense
-20,52 m
-20,92 m
-20,79 m
-21,83 m
Net interest expenses
-19,56 m
-16,14 m
-20,43 m
-20,77 m
Depreciation and amortization charges
-
-
-
-
EBITDA
49,45 m
34,84 m
45,66 m
35,97 m
Gain or loss from assets sale
-48,35 k
45,61 k
-
-
AI content may include mistakes. Learn more
Google-programme